Medical Updates on HIV Diagnosis Market to 2021 - Industry Shares, Top Companies, Demand Analysis, Geographical Forecast and Overview
Major factors contributing to growth of global HIV diagnosis market include increasing prevalence of HIV/AIDS worldwide, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments & kits, and increasing gove
(EMAILWIRE.COM, October 04, 2018 ) HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021. Factors like growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments & kits, & increasing government initiatives are expected to drive growth of market worldwide. Get Sample of this Study Report at http://www.rnrmarketresearch.com/contacts/request-sample?rname=911543 .
HIV diagnosis market is segmented into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests.The antibody tests segment is expected to account for the largest share of the HIV diagnosis market in 2016.These tests are widely adopted to screening and confirmation of HIV antibodies.
Target Audience for this Report:
• Manufacturers of HIV Diagnosis Products
• Vendors and Distributors of Powered Surgical Instruments
• Hospitals
• Research Institutes Related to HIV/AIDS Studies
• Venture Capitalists and Investors
This HIV diagnosis market report provides insights into the global HIV diagnosis market. It provides valuable information on the product, test type, and region in market. The geographic analysis for these segments is also presented in this report. Leading players in market are profiled to study their product offerings and understand strategies undertaken by them to be competitive in this market. Above-mentioned information would help buyer understand market dynamics.
Complete Report on HIV Diagnosis Market spread across 137 Pages, Profiling 11 Companies and Supported with 72 Tables and 53 Figures is now available at http://www.rnrmarketresearch.com/hiv-diagnosis-market-by-test-type-antibody-elisa-rapid-western-blot-viral-load-cd4-count-early-infant-viral-identification-product-assay-kit-reagent-instrument-software-services-end-user-hospitals-st-to-2021-market-report.html .
HIV diagnosis market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). Increasing awareness about HIV/AIDS and advancements in PoC instruments and consumables are major drivers for this end-user segment. Increasing prevalence of HIV/AIDS, increasing awareness about HIV, increasing blood donations and transfusions, and advancements in technology are expected to drive the growth of this market.
The major players in the HIV diagnosis market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).
Get 22% Discount and More Information “HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021” report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=911543 .
Geographically, North America dominates the global HIV diagnosis market. The government initiatives and funding in order to increase HIV diagnosis procedures and create awareness amongst the pollution and increasing number of blood transfusions are increasing the demand for HIV diagnosis products in North America.
On the other hand, the high cost of NAT and lack of mandates for NAT in developing countries are the major factors restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the HIV diagnosis market.
HIV diagnosis market is segmented into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests.The antibody tests segment is expected to account for the largest share of the HIV diagnosis market in 2016.These tests are widely adopted to screening and confirmation of HIV antibodies.
Target Audience for this Report:
• Manufacturers of HIV Diagnosis Products
• Vendors and Distributors of Powered Surgical Instruments
• Hospitals
• Research Institutes Related to HIV/AIDS Studies
• Venture Capitalists and Investors
This HIV diagnosis market report provides insights into the global HIV diagnosis market. It provides valuable information on the product, test type, and region in market. The geographic analysis for these segments is also presented in this report. Leading players in market are profiled to study their product offerings and understand strategies undertaken by them to be competitive in this market. Above-mentioned information would help buyer understand market dynamics.
Complete Report on HIV Diagnosis Market spread across 137 Pages, Profiling 11 Companies and Supported with 72 Tables and 53 Figures is now available at http://www.rnrmarketresearch.com/hiv-diagnosis-market-by-test-type-antibody-elisa-rapid-western-blot-viral-load-cd4-count-early-infant-viral-identification-product-assay-kit-reagent-instrument-software-services-end-user-hospitals-st-to-2021-market-report.html .
HIV diagnosis market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). Increasing awareness about HIV/AIDS and advancements in PoC instruments and consumables are major drivers for this end-user segment. Increasing prevalence of HIV/AIDS, increasing awareness about HIV, increasing blood donations and transfusions, and advancements in technology are expected to drive the growth of this market.
The major players in the HIV diagnosis market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).
Get 22% Discount and More Information “HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021” report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=911543 .
Geographically, North America dominates the global HIV diagnosis market. The government initiatives and funding in order to increase HIV diagnosis procedures and create awareness amongst the pollution and increasing number of blood transfusions are increasing the demand for HIV diagnosis products in North America.
On the other hand, the high cost of NAT and lack of mandates for NAT in developing countries are the major factors restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the HIV diagnosis market.
Contact Information:
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results